2型糖尿病合并非酒精性脂肪肝的危险因素研究(3)
[4]William T，Cefalu MD.Standards of medical care in diadetes-2017[J].Diabetes Care January，2017(40)：1.
[5]Chalasani N，Younossi Z，Lavine JE，et al. The diagnosis and management of non-alcoholic fatty liver disease： practice Guideline by the American Association for the Study of Liver Diseases， American College of Gastroenterology， and the American Gastroenterological Association[J].Hepatology，2012，55(6)：2005-2023.
[6]Singal AG，Manjunath H，Yopp AC，et al.The effect of PNPLA3 on fibrosis progression and development of hepatocellular carcinoma： a meta-analysis[J].Am J Gastroenterol，2014，109(3)：325-334.
[7]Bril F，Cusi K. Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes： A Call to Action[J].Diabetes Care，2017，40(3)：419-430.
[8]Inzucchi SE，Bergenstal RM，Buse JB.Management of hyperglycaemia in type 2 diabetes， 2015： a patient-centred approach.Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes[J].Diabetologia，2015(58)：429-442.
[9]Siddiqui MS，Fuchs M，Idowu MO，et al.Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile[J].Clin Gastroenterol Hepatol，2015(13)：1000-1008.
收稿日期：2018-9-30；修回日期：2018-10-11
編辑/王朵梅, http://www.100md.com(刘瑜 王星 代萌)
[5]Chalasani N，Younossi Z，Lavine JE，et al. The diagnosis and management of non-alcoholic fatty liver disease： practice Guideline by the American Association for the Study of Liver Diseases， American College of Gastroenterology， and the American Gastroenterological Association[J].Hepatology，2012，55(6)：2005-2023.
[6]Singal AG，Manjunath H，Yopp AC，et al.The effect of PNPLA3 on fibrosis progression and development of hepatocellular carcinoma： a meta-analysis[J].Am J Gastroenterol，2014，109(3)：325-334.
[7]Bril F，Cusi K. Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes： A Call to Action[J].Diabetes Care，2017，40(3)：419-430.
[8]Inzucchi SE，Bergenstal RM，Buse JB.Management of hyperglycaemia in type 2 diabetes， 2015： a patient-centred approach.Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes[J].Diabetologia，2015(58)：429-442.
[9]Siddiqui MS，Fuchs M，Idowu MO，et al.Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile[J].Clin Gastroenterol Hepatol，2015(13)：1000-1008.
收稿日期：2018-9-30；修回日期：2018-10-11
編辑/王朵梅, http://www.100md.com(刘瑜 王星 代萌)